Advertisement
BAX vs LUNG
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Hold and LUNG is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BAX’s FA Score shows that 2 FA rating(s) are green whileLUNG’s FA Score has 1 green FA rating(s).
- BAX’s FA Score: 2 green, 3 red.
- LUNG’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BAX’s TA Score shows that 5 TA indicator(s) are bullish while LUNG’s TA Score has 6 bullish TA indicator(s).
- BAX’s TA Score: 5 bullish, 4 bearish.
- LUNG’s TA Score: 6 bullish, 4 bearish.
Price Growth
BAX (@Pharmaceuticals: Other) experienced а -2.98% price change this week, while LUNG (@Medical/Nursing Services) price change was +18.63% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.26%. For the same industry, the average monthly price growth was +8.63%, and the average quarterly price growth was +6.97%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.55%. For the same industry, the average monthly price growth was +1.91%, and the average quarterly price growth was -4.26%.
Reported Earning Dates
BAX is expected to report earnings on Oct 29, 2026.
LUNG is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+3.26% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+1.55% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| BAX | LUNG | BAX / LUNG | |
| Capitalization | 13.8B | 105M | 13,143% |
| EBITDA | 762M | -48.22M | -1,580% |
| Gain YTD | 40.016 | 9.502 | 421% |
| P/E Ratio | 87.85 | N/A | - |
| Revenue | 11.5B | 88.5M | 12,994% |
| Total Cash | 2.15B | 61.6M | 3,490% |
| Total Debt | 9.67B | 56.3M | 17,171% |
BAX | LUNG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 84 | 45 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 29 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 96 | 99 | |
PRICE GROWTH RATING 1..100 | 5 | 36 | |
P/E GROWTH RATING 1..100 | 33 | 100 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LUNG's Valuation (29) in the null industry is somewhat better than the same rating for BAX (92) in the Medical Specialties industry. This means that LUNG’s stock grew somewhat faster than BAX’s over the last 12 months.
LUNG's Profit vs Risk Rating (100) in the null industry is in the same range as BAX (100) in the Medical Specialties industry. This means that LUNG’s stock grew similarly to BAX’s over the last 12 months.
BAX's SMR Rating (96) in the Medical Specialties industry is in the same range as LUNG (99) in the null industry. This means that BAX’s stock grew similarly to LUNG’s over the last 12 months.
BAX's Price Growth Rating (5) in the Medical Specialties industry is in the same range as LUNG (36) in the null industry. This means that BAX’s stock grew similarly to LUNG’s over the last 12 months.
BAX's P/E Growth Rating (33) in the Medical Specialties industry is significantly better than the same rating for LUNG (100) in the null industry. This means that BAX’s stock grew significantly faster than LUNG’s over the last 12 months.
| BAX | LUNG | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 58% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 60% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 67% | 1 day ago 79% |
| MACD ODDS (%) | 1 day ago 74% | 1 day ago 81% |
| TrendWeek ODDS (%) | 1 day ago 66% | 1 day ago 81% |
| TrendMonth ODDS (%) | 1 day ago 64% | 1 day ago 77% |
| Advances ODDS (%) | 11 days ago 57% | 12 days ago 79% |
| Declines ODDS (%) | 3 days ago 65% | 10 days ago 83% |
| BollingerBands ODDS (%) | 1 day ago 52% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 70% | 1 day ago 90% |
Advertisement
LUNG and
Correlation & Price change
A.I.dvisor indicates that over the last year, LUNG has been loosely correlated with SRTS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if LUNG jumps, then SRTS could also see price increases.
| Ticker / NAME | Correlation To LUNG | 1D Price Change % | ||
|---|---|---|---|---|
| LUNG | 100% | +12.04% | ||
| SRTS - LUNG | 57% Loosely correlated | -9.49% | ||
| BAX - LUNG | 53% Loosely correlated | -1.18% | ||
| ALGN - LUNG | 52% Loosely correlated | +2.90% | ||
| UTMD - LUNG | 32% Poorly correlated | -1.53% | ||
| BFLY - LUNG | 30% Poorly correlated | -0.23% | ||
More | ||||